AbCellera Biologics Inc. ABCL Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s payments to acquire property, plant, and equipment?
- AbCellera Biologics Inc. (ABCL) reported payments to acquire property, plant, and equipment of $3.83M in Q1 2026.
- How has AbCellera Biologics Inc.'s payments to acquire property, plant, and equipment changed year-over-year?
- AbCellera Biologics Inc.'s payments to acquire property, plant, and equipment decreased by 64.0% year-over-year, from $10.64M to $3.83M.
- What is the long-term trend for AbCellera Biologics Inc.'s payments to acquire property, plant, and equipment?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s payments to acquire property, plant, and equipment has grown at a -7.5% compound annual growth rate (CAGR), from $58.45M to $42.77M.
- What does payments to acquire property, plant, and equipment mean?
- This metric represents the cash outflows for capital expenditures used to acquire or upgrade physical assets such as laboratory equipment and facilities. It indicates the level of investment in the company's infrastructure to support long-term operational capacity.